BIO Asia–Taiwan 2021 亞洲生技大會

BIO Asia–Taiwan 2021 亞洲生技大會

講師

SYNG Pharmaceuticals Inc.

 

Company Info

Name /SYNG Pharmaceuticals Inc.

Address /623 Fortune Cres. #100, Kingston ON K7P 0L5, Canada

Website /www.syngpharma.com

Presenter

Name /Dr. Vinay Singh

Title /Founder & CEO

Email /vinay@syngpharma.com

Telephone /(Work) 613-532-9426

Fax /

Mobile /613-532-9426

Company Type

Biotechnology,Device

About the Company

SYNG Pharmaceuticals Inc. (SYNG Pharma) is an emerging stage biotech developing a new first-in-class diagnostic test and therapeutic for endometriosis. SYNG Pharma's non-invasive ELISA Test EndoID is available for commercialization as a lab-based screening test.

Brief Description of main products or services

Endometriosis impacts over 200 million women worldwide, is an over $2B market with no simple diagnostic or non-hormonal therapy.

Therapy – SYNG has completed animal and toxicity studies for a peptide-based non-hormonal therapy for endometriosis to replace currently available drugs with significant side effects.

Diagnostic - SYNG Pharma is ready to commercialize a simple blood-test EndoID. SYNG has completed POC prototypes for at-home use lateral flow device for women to screen endometriosis.

Contact Person

Name /Dr. Vinay Singh

Email /vinay@syngpharma.com

Phone /+1-613-532-9426